Skip to main content
ATHE logo

Alterity Therapeutics Limited

ATHENASDAQHealthcareBiotechnology

$2.08Today:- (-)1Y −53.26%

As of Oct 26, 2026 close

Market cap
$36.49M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.35$5.89
Volume (live)
-
Avg. volume (3M)
24.93K

Alterity Therapeutics (ATHE) Balance Sheet

As of Jun 30, 2026 (end of fiscal 2026), Alterity Therapeutics reported total assets of AUD 46.02M and total liabilities of AUD 3.29M. Shareholders' equity was AUD 42.72M, up 0.8% from AUD 42.40M a year earlier. Total debt stood at AUD 193.47K against AUD 37.32M in cash and short-term investments, a net cash position of AUD 37.12M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Alterity Therapeutics Balance Sheet Analysis

Values in millions AUD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Alterity Therapeutics Limited (ATHE) - Annual data in millions AUD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Current Assets
Cash and Cash Equivalents37.3233.1612.6415.7734.8128.129.2014.4015.2421.88
Short-Term Investments0.007.500.000.000.000.000.000.000.010.04
Cash & Short-Term Investments37.3240.6612.6415.7734.8128.129.2014.4015.2521.93
Accounts Receivable7.703.944.040.074.734.130.064.833.153.04
Inventory0.000.000.000.000.000.000.570.620.260.24
Other Current Assets0.048.772.360.040.011.253.410.630.260.29
Total Current Assets45.8345.8719.0427.0541.1433.4913.2319.8618.6525.25
Non-Current Assets
Property, Plant & Equipment (Net)0.190.160.190.270.220.100.070.050.070.03
Other Non-Current Assets0.000.000.000.000.000.000.00-0.05-0.07-0.03
Total Non-Current Assets0.190.160.190.270.220.100.070.050.070.03
Total Assets46.0246.0319.2227.3241.3633.5913.3019.9118.7325.28
Current Liabilities
Accounts Payable1.122.580.581.725.081.450.951.691.330.07
Short-Term Debt0.060.070.110.110.060.030.030.000.000.00
Accrued Liabilities0.890.884.021.772.360.54----
Deferred Revenue0.000.000.00-0.11-0.060.00-0.030.000.000.00
Other Current Liabilities0.000.024.670.03-0.031.591.761.631.311.53
Total Current Liabilities3.163.535.374.385.823.072.713.322.641.59
Non-Current Liabilities
Long-Term Debt0.140.090.050.100.060.040.000.000.000.00
Other Non-Current Liabilities0.000.000.000.020.010.010.040.030.000.00
Total Non-Current Liabilities0.140.090.050.120.070.050.040.030.000.00
Total Liabilities3.293.625.434.505.893.122.763.362.641.59
Stockholders' Equity
Common Stock282.51262.95223.15213.97213.79197.45160.70156.63143.91144.02
Retained Earnings-245.58-225.89-214.16-195.13-181.88-169.73-151.02-141.24-129.58-122.65
Accumulated Other Comprehensive Income5.805.344.813.973.572.750.871.161.752.32
Shares Outstanding217.51182.55104.9048.8048.14-----
Total Stockholders' Equity42.7242.4013.8022.8135.4730.4710.5516.5516.0823.69
Total Liabilities & Equity46.0246.0319.2227.3241.3633.5913.3019.9118.7325.28

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Alterity Therapeutics Balance Sheet

How much debt does Alterity Therapeutics have?

Alterity Therapeutics had total debt of AUD 193.47K as of Jun 30, 2026, against AUD 37.32M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was AUD 155.46K a year earlier.

What are Alterity Therapeutics's total assets?

Alterity Therapeutics reported total assets of AUD 46.02M as of Jun 30, 2026, flat from AUD 46.03M a year earlier. Total liabilities were AUD 3.29M.

What is Alterity Therapeutics's shareholders' equity?

Alterity Therapeutics's shareholders' equity was AUD 42.72M as of Jun 30, 2026, or about AUD 0.20 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition